- Global Pharma News & Resources

Share Dealing and Exercise of Options

Share Dealing and Exercise of Options

LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces the exercise of options by an employee of the Company.

An employee has exercised options over 20,000 shares of common stock of US$0.001 each in the Company ("Common Stock") with an exercise price of $00.21 per Share.  Accordingly the employee will be issued 20,000 shares of Common Stock in the Company. 

The Shares will be restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Section 904 of Regulation S under the US Securities Act of 1933, as amended.

The Company will apply for 20,000 Shares to be admitted to trading on AIM, with admission expected to take place at 8:00 a.m. on or around 31 December 2021 ("Admission"). The Shares will rank pari passu in all respects with the Common Stock. There is no Common Stock held in treasury.

Following Admission, the total number of shares of Common Stock in issue will be 136,097,064, with one voting right per share of Common Stock.  Therefore, the total number of voting rights in the Company will be 136,097,064

Consequently, the above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Company's Certificate of Incorporation.


For further information, please contact:




Spectral MD Holdings, Ltd.

Wensheng Fan, Chief Executive Officer

Nils Windler, Chief Financial Officer

via Walbrook PR

Editor Details

Last Updated: 24-Dec-2021